BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
木曜日, 9 24

Veradermics Inc

MANENYSE
Trade with Public
Trade with Public
$117.84
2.061.78%
最終更新: Sep 24, 9:45 AM
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Veradermics Earnings & Forecasts

Veradermics (MANE) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

Veradermics Guidance

Recent Earnings Results

MetricQ2 '26Q1 '26Q4 '25
Earnings Per Share (Non-GAAP)
Estimate$-0.63$-0.79$-0.66
Actual$-0.58$-1.32$-0.62
Surprise+7.94%-67.1%+6.06%
Revenue
Estimate———
Actual$0$0$0
Surprise———
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
MetricQ3 '26EQ4 '26E
Earnings Per Share (Non-GAAP)
Consensus$-0.59$-0.62
Revenue
Consensus——
More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
Veradermics Q2 EPS $(0.58) Beats $(0.65) Estimate

Veradermics (NYSE:MANE) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.65) by 10.77 percent. This is a 97.6 percent increase over losses of $(24.19) per share from the
Benzinga Newsdesk

PRO
Veradermics Q4 EPS $(0.62) Beats $(0.66) Estimate

Veradermics (NYSE:MANE) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.66) by 6.06 percent.
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved